Incorrect disease risk. The article, “The Pregnant Patient: Managing Common Acute Medical Problems” (November 1, 2018, p. 595), contained an error in the third sentence of the second paragraph of the “Dysuria” section in the first column on page 601 regarding the use of trimethoprim/sulfamethoxazole in pregnant patients and the associated risks to the newborn. This sentence should have read, “Trimethoprim/sulfamethoxazole is generally not recommended for use in pregnancy because of risks of neural tube defects in early pregnancy, as well as kernicterus in the newborn and permanent neonatal neurologic damage.” The online version of the article has been corrected.